Elevated parathyroid hormone 44-68 and osteoarticular changes in patients with genetic hemochromatosis

Arthritis Rheum. 1999 Apr;42(4):799-806. doi: 10.1002/1529-0131(199904)42:4<799::AID-ANR25>3.0.CO;2-4.

Abstract

Objective: To determine whether the osteoarticular changes associated with genetic hemochromatosis could be explained by metabolic parathyroid hormone (PTH) disorders.

Methods: The study involved 210 patients with liver iron overload syndromes. Osteoarticular changes were numerically scored as the number of damaged joints. PTH 1-84 and 44-68 were assayed.

Results: An increase in serum PTH 44-68 levels was found in one-third of untreated patients who had no calcium or PTH 1-84 abnormalities. Serum PTH 44-68 levels correlated positively with serum ferritin levels. In multivariate analyses, the number of affected joints correlated positively with age, serum PTH 44-68 levels, and serum ferritin levels.

Conclusion: Liver iron overload syndromes, especially genetic hemochromatosis, are associated with elevated circulating levels of PTH fragments containing the 44-68 region, which appears to play a role in osteoarticular changes. This increase seems to be a consequence of iron overload.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Chondrocalcinosis / complications
  • Chondrocalcinosis / metabolism*
  • Chondrocalcinosis / pathology
  • Female
  • Ferritins / blood
  • Hemochromatosis / complications
  • Hemochromatosis / genetics
  • Hemochromatosis / metabolism*
  • Humans
  • Iron / metabolism
  • Joints / metabolism
  • Joints / pathology
  • Liver / metabolism
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Parathyroid Hormone / blood*
  • Peptide Fragments / blood*
  • Transferrin / metabolism

Substances

  • Parathyroid Hormone
  • Peptide Fragments
  • Transferrin
  • parathyroid hormone (44-68)
  • Ferritins
  • Iron